000 | 01605 a2200445 4500 | ||
---|---|---|---|
005 | 20250511220604.0 | ||
264 | 0 | _c19910703 | |
008 | 199107s 0 0 eng d | ||
022 | _a0007-1250 | ||
024 | 7 |
_a10.1192/bjp.158.3.351 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHunter, R | |
245 | 0 | 0 |
_aCerebral pharmacodynamics of physostigmine in Alzheimer's disease investigated using single-photon computerised tomography. _h[electronic resource] |
260 |
_bThe British journal of psychiatry : the journal of mental science _cMar 1991 |
||
300 |
_a351-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAlzheimer Disease _xdiagnostic imaging |
650 | 0 | 4 |
_aArousal _xdrug effects |
650 | 0 | 4 |
_aAttention _xdrug effects |
650 | 0 | 4 |
_aBlood Flow Velocity _xdrug effects |
650 | 0 | 4 |
_aBrain _xblood supply |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeuropsychological Tests |
650 | 0 | 4 |
_aPhysostigmine _xtherapeutic use |
650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
650 | 0 | 4 | _aSingle-Blind Method |
650 | 0 | 4 | _aTomography, Emission-Computed, Single-Photon |
700 | 1 | _aWyper, D J | |
700 | 1 | _aPatterson, J | |
700 | 1 | _aHansen, M T | |
700 | 1 | _aGoodwin, G M | |
773 | 0 |
_tThe British journal of psychiatry : the journal of mental science _gvol. 158 _gp. 351-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1192/bjp.158.3.351 _zAvailable from publisher's website |
999 |
_c2042715 _d2042715 |